Related references
Note: Only part of the references are listed.The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive, First-Line Metastatic Breast Cancer
Jose Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Tumour-infiltrating CD8+lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
A. N. Seo et al.
BRITISH JOURNAL OF CANCER (2013)
Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer - A Substudy of the Neoadjuvant GeparQuinto Trial
Yasmin Issa-Nummer et al.
PLOS ONE (2013)
CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis
Ross Brown et al.
BLOOD (2012)
FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
K. Tamura et al.
ANNALS OF ONCOLOGY (2011)
Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs
Arthur Machlenkin et al.
CANCER RESEARCH (2008)
Intercellular trogocytosis plays an important role in modulation of immune responses
Khawaja Ashfaque Ahmed et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Binding of Rituximab, Trastuzumab, Cetuximab, or mAb T101 to Cancer Cells Promotes Trogocytosis Mediated by THP-1 Cells and Monocytes
Paul V. Beum et al.
JOURNAL OF IMMUNOLOGY (2008)
Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8+ T cells
J. Riond et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133, CD15, and CD24
David M. Panchision et al.
STEM CELLS (2007)
Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells
Joel LeMaoult et al.
BLOOD (2007)
Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response
Daniel M. Davis
NATURE REVIEWS IMMUNOLOGY (2007)
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure
S Abouzahr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer
R Sáez et al.
CLINICAL CANCER RESEARCH (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis:: a model for lentivirus-induced T cell depletion
TW Vahlenkamp et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2004)
Human and murine inhibitory natural killer cell receptors transfer from natural killer cells to target cells
B Vanherberghen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance
D Hudrisier et al.
FASEB JOURNAL (2002)
Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses
LM Carlin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Acquisition of CD80 (B7-1) by T cells
H Sabzevari et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
